Your browser doesn't support javascript.
loading
Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil
Papi, Luanda; Menezes, Ana Carolina G.B.; Rocha, Hélio; Abreu, Thalita F.; Oliveira, Ricardo Hugo de; Frota, Ana Cristina C.; Evangelista, Lucia de A.; Hofer, Cristina B..
Afiliação
  • Papi, Luanda; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Menezes, Ana Carolina G.B.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Rocha, Hélio; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Abreu, Thalita F.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Oliveira, Ricardo Hugo de; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Frota, Ana Cristina C.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Evangelista, Lucia de A.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Hofer, Cristina B.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
Braz. j. infect. dis ; 18(4): 394-399, Jul-Aug/2014. tab, graf
Article em En | LILACS | ID: lil-719294
Biblioteca responsável: BR1.1
ABSTRACT
The aim of present study was to describe the frequency of lipodystrophy syndrome associated with HIV (LSHIV) and factors associated with dyslipidemia in Brazilian HIV infected children. HIV infected children on antiretroviral treatment were evaluated (nutritional assessment, physical examination, and laboratory tests) in this cross-sectional study. Univariate analysis was performed using Mann-Whitney test or Fisher's exact test followed by logistic regression analysis. Presence of dyslipidemia (fasting cholesterol >200 mg/dl or triglycerides >130 mg/dl) was the dependent variable. 90 children were enrolled. The mean age was 10.6 years (3-16 years), and 52 (58%) were female. LSHIV was detected in 46 children (51%). Factors independently associated with dyslipidemia were low intake of vegetables/fruits (OR = 3.47, 95%CI = 1.04-11.55), current use of lopinavir/ritonavir (OR = 2.91, 95%CI = 1.11-7.67). In conclusion, LSHIV was frequently observed; inadequate dietary intake of sugars and fats, as well as current use of lopinavir/ritonavir was associated with dyslipidemia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Assunto principal: Fármacos Anti-HIV / Síndrome de Lipodistrofia Associada ao HIV / Dislipidemias Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Assunto principal: Fármacos Anti-HIV / Síndrome de Lipodistrofia Associada ao HIV / Dislipidemias Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Brasil